ArticleOphthalmology and therapy2018

Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting.

Maria Eleftheriadou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.